0001567619-23-005059.txt : 20230314
0001567619-23-005059.hdr.sgml : 20230314
20230314194022
ACCESSION NUMBER: 0001567619-23-005059
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230310
FILED AS OF DATE: 20230314
DATE AS OF CHANGE: 20230314
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BIENAIME JEAN JACQUES
CENTRAL INDEX KEY: 0001221590
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26727
FILM NUMBER: 23732859
MAIL ADDRESS:
STREET 1: 925 PAGE MILL ROAD
CITY: PALO ALTO
STATE: CA
ZIP: 94304
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC
CENTRAL INDEX KEY: 0001048477
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 680397820
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
BUSINESS PHONE: 4155066700
MAIL ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
4
1
doc1.xml
FORM 4
X0306
4
2023-03-10
0
0001048477
BIOMARIN PHARMACEUTICAL INC
BMRN
0001221590
BIENAIME JEAN JACQUES
C/O BIOMARIN PHARMACEUTICAL INC.
770 LINDARO ST.
SAN RAFAEL
CA
94901
1
1
0
0
Chief Executive Officer
Common Stock
2023-03-10
4
M
0
15000
67.81
A
502856
D
Common Stock
2023-03-10
4
S
0
15000
92.28
D
487856
D
Common Stock
2023-03-13
4
M
0
8000
67.81
A
495856
D
Common Stock
2023-03-13
4
S
0
8000
90.45
D
487856
D
Common Stock
247333
I
Shares held by Jean-Jacques Bienaime Family Trust
Common Stock
100
I
Shares held as UTMA custodian for child
Common Stock
100
I
Shares held as UTMA custodian for child
Stock Option (Right to buy Common Stock)
67.81
2023-03-10
4
M
0
15000
0
D
2013-11-15
2023-05-14
Common Stock
15000
157130
D
Stock Option (Right to buy Common Stock)
67.81
2023-03-13
4
M
0
8000
0
D
2013-11-15
2023-05-14
Common Stock
8000
149130
D
Trade made pursuant to a 10b5-1 plan executed on May 3, 2022.
Trade made pursuant to a 10b5-1 plan executed on November 17, 2022.
Reflects the number of options outstanding after the transactions from this specific stock option grant.
/s/ Eric Fleekop, Attorney-in-Fact
2023-03-14